Teva- Pharmaceutical Industries Common Stock

Teva- Pharmaceutical Industries (TEVA) currently reports a common stock of $-4.1B as of March 2026. That compares with $58M in the prior-year period — down 7115.5% year over year. Use the charts on this page to explore Teva- Pharmaceutical Industries's common stock history and peer comparisons.

Teva- Pharmaceutical Industries's common stock decreased from $58M to $-4.1B — a 7115.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Teva- Pharmaceutical Industries reported $-4.1B in common stock as of March 2026. That compares with $58M in the prior-year period — down 7115.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $-4.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Teva- Pharmaceutical Industries, and consider following TEVA for alerts when major investors trade the stock.

Teva- Pharmaceutical Industries is classified in the Healthcare sector. On common stock, it currently shows $-4.1B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TEVA with unrelated industries.